Savara Secures Path to $150M as FDA Decision Nears for Rare Lung Drug
LANGHORNE, PA — Savara Inc. (Nasdaq: SVRA) said it has amended its loan and security agreement with Hercules Capital, Inc. (NYSE: HTGC), unlocking significant non-dilutive financing tied to a pending …
Savara Secures Path to $150M as FDA Decision Nears for Rare Lung Drug Read More